All Stories

  1. Protective Effects of Extracts from Green Leaves and Rhizomes of Posidonia oceanica (L.) Delile on an In Vitro Model of the Human Blood–Brain Barrier

    Article • Biology, June 2025, MDPI AG

    Pr. Fabien Gosselet

  2. 25-Hydroxycholesterol attenuates tumor necrosis factor alpha-induced blood-brain barrier breakdown in vitro

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, December 2024, Elsevier

    Pr. Fabien Gosselet

  3. Erratum to “CD31 orchestrates metabolic regulation in autophagy pathways of rheumatoid arthritis” [Pharmacol. Res. 207 (2024) 107346]

    Article • Pharmacological Research, October 2024, Elsevier

    Pr. Fabien Gosselet

  4. CD31 orchestrates metabolic regulation in autophagy pathways of rheumatoid arthritis

    Article • Pharmacological Research, September 2024, Elsevier

    Pr. Fabien Gosselet

  5. Secretome of brain microvascular endothelial cells promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage

    Article • Extremophiles, August 2024, Springer Science + Business Media

    Pr. Fabien Gosselet

  6. Enterovirus A71 crosses a human blood–brain barrier model through infected immune cells

    Article • Microbiology Spectrum, June 2024, ASM Journals

    Pr. Fabien Gosselet

  7. Synergistic induction of blood–brain barrier properties

    Article • Proceedings of the National Academy of Sciences, May 2024, Proceedings of the National Academy of Sciences

    Dr Maria A Deli, Pr. Fabien Gosselet

  8. Retraction Note: Secretome of endothelial progenitor cells from stroke patients promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage

    Article • Stem Cell Research & Therapy, February 2024, Springer Science + Business Media

    Pr. Fabien Gosselet

  9. Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model

    Article • Pharmaceutics, January 2024, MDPI AG

    Prof Yogeshvar Kalia, Pr. Fabien Gosselet

  10. 25-Hydroxycholesterol in health and diseases

    Article • Journal of Lipid Research, January 2024, Elsevier

    Pr. Fabien Gosselet

  11. BrainBike peptidomimetic enables efficient transport of proteins across brain endothelium

    Article • RSC Chemical Biology, January 2024, Royal Society of Chemistry

    Pr. Fabien Gosselet

  12. Vesicular Trafficking, a Mechanism Controlled by Cascade Activation of Rab Proteins: Focus on Rab27

    Article • Biology, December 2023, MDPI AG

    Pr. Fabien Gosselet

  13. ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells

    Article • Experimental Hematology and Oncology, December 2023, Springer Science + Business Media

    Pr. Fabien Gosselet

  14. Discovery, Structure–Activity Relationships, and In Vivo Activity of Dihydropyridone Agonists of the Bile Acid Receptor TGR5

    Article • Journal of Medicinal Chemistry, August 2023, American Chemical Society (ACS)

    Pr. Fabien Gosselet

  15. High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro

    Article • Journal of Neuroinflammation, May 2023, Springer Science + Business Media

    Pr. Fabien Gosselet

  16. Differential Blood–Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro

    Article • Pharmaceutics, May 2023, MDPI AG

    Pr. Fabien Gosselet

  17. Challenges and Opportunities in the Oral Delivery of Recombinant Biologics

    Article • Pharmaceutics, May 2023, MDPI AG

    Pr. Fabien Gosselet

  18. Highlighting In Vitro the Role of Brain-like Endothelial Cells on the Maturation and Metabolism of Brain Pericytes by SWATH Proteomics

    Article • Cells, March 2023, MDPI AG

    Pr. Fabien Gosselet

  19. Impact of Pesticide Residues on the Gut-Microbiota–Blood–Brain Barrier Axis: A Narrative Review

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Pr. Fabien Gosselet

  20. TNFα Activates the Liver X Receptor Signaling Pathway and Promotes Cholesterol Efflux from Human Brain Pericytes Independently of ABCA1

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Pr. Fabien Gosselet

  21. Synergistic induction of blood-brain barrier properties

    Article • February 2023, Cold Spring Harbor Laboratory Press

    Pr. Fabien Gosselet

  22. Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood–Brain Barrier Model Derived from Hematopoietic Stem Cells

    Article • Cells, December 2022, MDPI AG

    Pr. Fabien Gosselet

  23. Pioglitazone Attenuates the Effects of Peripheral Inflammation in a Human In Vitro Blood–Brain Barrier Model

    Article • International Journal of Molecular Sciences, October 2022, MDPI AG

    Pr. Fabien Gosselet

  24. Challenges and opportunities in the use of transcriptomic characterization of human iPSC-derived BBB models

    Article • Toxicology in Vitro, October 2022, Elsevier

    Pr. Fabien Gosselet

  25. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model

    Article • International Journal of Molecular Sciences, September 2022, MDPI AG

    Pr. Fabien Gosselet

  26. Antimalarial Drug Discovery: From Quinine to the Most Recent Promising Clinical Drug Candidates

    Article • Current Medicinal Chemistry, June 2022, Bentham Science Publishers

    Pr. Fabien Gosselet

  27. Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells

    Article • International Journal of Pharmaceutics, June 2022, Elsevier

    Pr. Fabien Gosselet

  28. Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells

    Article • Journal of Experimental & Clinical Cancer Research, March 2022, Springer Science + Business Media

    Pr. Fabien Gosselet

  29. A New Class of Bi- and Trifunctional Sugar Oximes as Antidotes against Organophosphorus Poisoning

    Article • Journal of Medicinal Chemistry, March 2022, American Chemical Society (ACS)

    Pr. Fabien Gosselet

  30. An In Vitro Human Blood–Brain Barrier Model to Study Breast Cancer Brain Metastasis

    Article • January 2022, Springer Science + Business Media

    Pr. Fabien Gosselet

  31. The Blood–Brain Barrier, an Evolving Concept Based on Technological Advances and Cell–Cell Communications

    Article • Cells, December 2021, MDPI AG

    Pr. Fabien Gosselet

  32. A Triple Culture Cell System Modeling the Human Blood-Brain Barrier

    Article • Journal of Visualized Experiments, November 2021, MyJove Corporation

    Pr. Fabien Gosselet

  33. RETRACTED ARTICLE: Secretome of endothelial progenitor cells from stroke patients promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage

    Article • Stem Cell Research & Therapy, October 2021, Springer Science + Business Media

    Pr. Fabien Gosselet

  34. Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier

    Article • Brain Behavior & Immunity - Health, October 2021, Elsevier

    Pr. Fabien Gosselet

  35. Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study

    Article • Biomaterials, September 2021, Elsevier

    Pr. Fabien Gosselet

  36. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects

    Article • Frontiers in Immunology, July 2021, Frontiers

    Pr. Fabien Gosselet

  37. Miniaturization and Automation of a Human In Vitro Blood–Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery

    Article • Pharmaceutics, June 2021, MDPI AG

    Pr. Fabien Gosselet

  38. Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound

    Article • Toxicology in Vitro, June 2021, Elsevier

    Pr. Fabien Gosselet

  39. Role of ABCA7 in Human Health and in Alzheimer’s Disease

    Article • International Journal of Molecular Sciences, April 2021, MDPI AG

    Pr. Fabien Gosselet

  40. Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation

    Article • European Journal of Medicinal Chemistry, April 2021, Elsevier

    Pr. Fabien Gosselet

  41. Central nervous system delivery of molecules across the blood-brain barrier

    Article • Neurochemistry International, March 2021, Elsevier

    Pr. Fabien Gosselet

  42. Endothelial Iron Homeostasis Regulates Blood-Brain Barrier Integrity via the HIF2α—Ve-Cadherin Pathway

    Article • Pharmaceutics, February 2021, MDPI AG

    Pr. Fabien Gosselet

  43. Correction to: Differential neurovirulence of Usutu viruslineages in mice and neuronal cells

    Article • Journal of Neuroinflammation, February 2021, Springer Science + Business Media

    Pr. Fabien Gosselet

  44. Flow induces barrier and glycocalyx-related genes and negative surface charge in a lab-on-a-chip human blood-brain barrier model

    Article • Journal of Cerebral Blood Flow & Metabolism, February 2021, SAGE Publications

    Pr. Fabien Gosselet

  45. Time-Dependent Internalization of Polymer-Coated Silica Nanoparticles in Brain Endothelial Cells and Morphological and Functional Effects on the Blood-Brain Barrier

    Article • International Journal of Molecular Sciences, February 2021, MDPI AG

    Pr. Fabien Gosselet

  46. Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor

    Article • Journal of Medicinal Chemistry, January 2021, American Chemical Society (ACS)

    Pr. Fabien Gosselet

  47. Differential neurovirulence of Usutu virus lineages in mice and neuronal cells

    Article • Journal of Neuroinflammation, January 2021, Springer Science + Business Media

    Pr. Fabien Gosselet

  48. Correction: PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities

    Article • Nanoscale, January 2021, Royal Society of Chemistry

    Pr. Fabien Gosselet

  49. Advancing human induced pluripotent stem cell‐derived blood‐brain barrier models for studying immune cell interactions

    Article • The FASEB Journal, October 2020, Wiley

    Pr. Fabien Gosselet

  50. Endothelial iron homeostasis regulates BBB integrity via the HIF2α – Ve-cadherin pathway

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Pr. Fabien Gosselet

  51. Naphthoquinone–Dopamine Hybrids Inhibit α‐Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate‐Induced Toxicity

    Article • Chemistry - A European Journal, October 2020, Wiley

    Pr. Fabien Gosselet

  52. Chemoselective Hydrogenation of 6‐Alkynyl‐3‐fluoro‐2‐pyridinaldoximes: Access to First‐in‐Class 6‐Alkyl‐3‐Fluoro‐2‐pyridinaldoxime Scaffolds as New Reactivators of Sarin‐Inhibited Human Acetylcholinesterase with Increased Blood–Brain Barrier Permeability

    Article • Chemistry - A European Journal, October 2020, Wiley

    Pr. Fabien Gosselet

  53. Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair

    Article • Journal of Neuroinflammation, September 2020, Springer Science + Business Media

    Pr. Fabien Gosselet

  54. First step to the improvement of the blood brain barrier passage of atazanavir encapsulated in sustainable bioorganic vesicles

    Article • International Journal of Pharmaceutics, September 2020, Elsevier

    Pr. Fabien Gosselet

  55. Zika Virus Infection Promotes Local Inflammation, Cell Adhesion Molecule Upregulation, and Leukocyte Recruitment at the Blood-Brain Barrier

    Article • mBio, August 2020, ASM Journals

    Pr. Fabien Gosselet

  56. Contribution of brain pericytes in blood–brain barrier formation and maintenance: a transcriptomic study of cocultured human endothelial cells derived from hematopoietic stem cells

    Article • Fluids and Barriers of the CNS, July 2020, Springer Science + Business Media

    Pr. Fabien Gosselet

  57. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies

    Article • International Journal of Molecular Sciences, June 2020, MDPI AG

    Pr. Fabien Gosselet

  58. The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel

    Article • International Journal of Molecular Sciences, June 2020, MDPI AG

    Dr Maria A Deli, Pr. Fabien Gosselet

  59. Efficacy Assessment of an Uncharged Reactivator of NOP-Inhibited Acetylcholinesterase Based on Tetrahydroacridine Pyridine-Aldoxime Hybrid in Mouse Compared to Pralidoxime

    Article • Biomolecules, June 2020, MDPI AG

    Pr. Fabien Gosselet

  60. Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance

    Article • Fluids and Barriers of the CNS, June 2020, Springer Science + Business Media

    Pr. Fabien Gosselet

  61. Study of Usutu virus neuropathogenicity in mice and human cellular models

    Article • PLoS Neglected Tropical Diseases, April 2020, PLOS

    Pr. Fabien Gosselet

  62. Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood–brain barrier model

    Article • Fluids and Barriers of the CNS, April 2020, Springer Science + Business Media

    Pr. Fabien Gosselet

  63. GM1 Oligosaccharide Crosses the Human Blood–Brain Barrier In Vitro by a Paracellular Route

    Article • International Journal of Molecular Sciences, April 2020, MDPI AG

    Pr. Fabien Gosselet

  64. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles

    Article • Cells, April 2020, MDPI AG

    Pr. Fabien Gosselet

  65. New Lipidyl-Cyclodextrins Obtained by Ring Opening of Methyl Oleate Epoxide Using Ball Milling

    Article • Biomolecules, February 2020, MDPI AG

    Pr. Fabien Gosselet, Professor Eric Monflier

  66. Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro

    Article • Fluids and Barriers of the CNS, February 2020, Springer Science + Business Media

    Pr. Fabien Gosselet

  67. Ketone Bodies Promote Amyloid-β1–40 Clearance in a Human in Vitro Blood–Brain Barrier Model

    Article • International Journal of Molecular Sciences, January 2020, MDPI AG

    Pr. Fabien Gosselet

  68. Nonionotropic Action of Endothelial NMDA Receptors on Blood–Brain Barrier Permeability via Rho/ROCK-Mediated Phosphorylation of Myosin

    Article • Journal of Neuroscience, January 2020, Society for Neuroscience

    Pr. Fabien Gosselet

  69. A High Output Method to Isolate Cerebral Pericytes from Mouse

    Article • Journal of Visualized Experiments, January 2020, MyJove Corporation

    Pr. Fabien Gosselet

  70. Transport Studies Using Blood-Brain Barrier In Vitro Models: A Critical Review and Guidelines

    Article • January 2020, Springer Science + Business Media

    Pr. Fabien Gosselet

  71. PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities

    Article • Nanoscale, January 2020, Royal Society of Chemistry

    Pr. Fabien Gosselet

  72. A Miniaturized Pump Out Method for Characterizing Molecule Interaction with ABC Transporters

    Article • International Journal of Molecular Sciences, November 2019, MDPI AG

    Pr. Fabien Gosselet

  73. Granisetron Alleviates Alzheimer’s Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway

    Article • Journal of Alzheimer’s Disease, October 2019, IOS Press

    Pr. Fabien Gosselet

  74. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model

    Article • Cellular and Molecular Life Sciences, September 2019, Springer Science + Business Media

    Pr. Fabien Gosselet

  75. Oxysterols and the NeuroVascular Unit (NVU): A far true love with bright and dark sides

    Article • The Journal of Steroid Biochemistry and Molecular Biology, July 2019, Elsevier

    Pr. Fabien Gosselet

  76. PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation

    Article • Frontiers in Immunology, April 2019, Frontiers

    Pr. Fabien Gosselet

  77. Transient blood–brain barrier disruption is induced by low pulsed electrical fields in vitro: an analysis of permeability and trans-endothelial electric resistivity

    Article • Drug Delivery, January 2019, Taylor & Francis

    Pr. Fabien Gosselet

  78. A silicon nanomembrane platform for the visualization of immune cell trafficking across the human blood–brain barrier under flow

    Article • Journal of Cerebral Blood Flow & Metabolism, December 2018, SAGE Publications

    Pr. Fabien Gosselet

  79. Corrigendum to “Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration” [Eur. J. Pharm. Biopharm. 127 (2018) 453–461]

    Article • European Journal of Pharmaceutics and Biopharmaceutics, December 2018, Elsevier

    Pr. Fabien Gosselet

  80. Blood-Brain Barrier Cellular Responses Toward Organophosphates: Natural Compensatory Processes and Exogenous Interventions to Rescue Barrier Properties

    Article • Frontiers in Cellular Neuroscience, October 2018, Frontiers

    Pr. Fabien Gosselet

  81. Exploring in vitro the potential effects of repeated drug treatment on the distribution of other xenobiotics at the human blood-brain barrier (BBB)

    Article • Toxicology Letters, October 2018, Elsevier

    Pr. Fabien Gosselet

  82. HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?

    Article • Frontiers in Cellular Neuroscience, September 2018, Frontiers

    Pr. Fabien Gosselet

  83. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier

    Article • Journal of Alzheimer’s Disease, July 2018, IOS Press

    Pr. Fabien Gosselet

  84. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment

    Article • International Journal of Pharmaceutics, July 2018, Elsevier

    Pr. Fabien Gosselet

  85. Sodium Transporters Are Involved in Lithium Influx in Brain Endothelial Cells

    Article • Molecular Pharmaceutics, June 2018, American Chemical Society (ACS)

    Pr. Fabien Gosselet

  86. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration

    Article • European Journal of Pharmaceutics and Biopharmaceutics, June 2018, Elsevier

    Pr. Fabien Gosselet

  87. Food-Derived Hemorphins Cross Intestinal and Blood–Brain Barriers In Vitro

    Article • Frontiers in Endocrinology, April 2018, Frontiers

    Pr. Fabien Gosselet

  88. Petits mais costauds

    Article • médecine/sciences, April 2018, EDP Sciences

    Pr. Fabien Gosselet

  89. Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers

    Article • Fluids and Barriers of the CNS, October 2017, Springer Science + Business Media

    Pr. Fabien Gosselet

  90. Brain tissue binding explains discrepancy between in vitro and in vivo methods for assessing blood–brain barrier permeability of chemicals

    Article • Toxicology Letters, October 2017, Elsevier

    Pr. Fabien Gosselet

  91. Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer’s Disease

    Article • Pharmaceutical Research, September 2017, Springer Science + Business Media

    Pr. Fabien Gosselet

  92. Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance

    Article • Journal of Medicinal Chemistry, May 2017, American Chemical Society (ACS)

    Pr. Fabien Gosselet

  93. Modélisation in vitro de la barrière hémato-encéphalique

    Article • médecine/sciences, April 2017, EDP Sciences

    Pr. Fabien Gosselet

  94. Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease

    Article • Molecules, February 2017, MDPI AG

    Pr. Fabien Gosselet

  95. Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases

    Article • Molecules, December 2016, MDPI AG

    Pr. Fabien Gosselet, Professor Eric Monflier

  96. ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood–brain barrier

    Article • Journal of Cerebral Blood Flow & Metabolism, November 2016, SAGE Publications

    Pr. Fabien Gosselet

  97. ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier

    Article • International Journal of Molecular Sciences, August 2016, MDPI AG

    Pr. Fabien Gosselet

  98. Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier

    Article • Journal of Alzheimer’s Disease, July 2016, IOS Press

    Pr. Fabien Gosselet

  99. In vitro blood–brain barrier permeability predictions for GABA A receptor modulating piperine analogs

    Article • European Journal of Pharmaceutics and Biopharmaceutics, June 2016, Elsevier

    Pr. Fabien Gosselet

  100. β-Cyclodextrins Decrease Cholesterol Release and ABC-Associated Transporter Expression in Smooth Muscle Cells and Aortic Endothelial Cells

    Article • Frontiers in Physiology, May 2016, Frontiers

    Pr. Fabien Gosselet, Professor Eric Monflier

  101. Pharmacokinetics and In Vitro Blood-Brain Barrier Screening of the Plant-Derived Alkaloid Tryptanthrin

    Article • Planta Medica, April 2016, Thieme Publishing Group

    Professor Matthias Hamburger, Dr Maria A Deli, Pr. Fabien Gosselet

  102. Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines

    Article • PLOS One, March 2016, PLOS

    Pr. Fabien Gosselet

  103. Adapting coculture in vitro models of the blood–brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration

    Article • Laboratory Investigation, February 2016, Springer Science + Business Media

    Pr. Fabien Gosselet

  104. Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models

    Article • Toxicology in Vitro, December 2015, Elsevier

    Professor Dieter G. Weiss, Pr. Fabien Gosselet

  105. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier

    Article • Journal of Alzheimer’s Disease, October 2015, IOS Press

    Pr. Fabien Gosselet

  106. Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid

    Article • Molecular Neurobiology, June 2015, Springer Science + Business Media

    Pr. Fabien Gosselet

  107. In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes

    Article • Brain Research, January 2015, Elsevier

    Pr. Fabien Gosselet

  108. Blood–Brain Barrier Proteomics: Towards the Understanding of Neurodegenerative Diseases

    Article • Archives of Medical Research, November 2014, Elsevier

    Pr. Fabien Gosselet

  109. Effects of oxysterols on the blood–brain barrier: Implications for Alzheimer’s disease

    Article • Biochemical and Biophysical Research Communications, April 2014, Elsevier

    Pr. Fabien Gosselet

  110. Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier

    Article • Current Alzheimer Research, December 2013, Bentham Science Publishers

    Pr. Fabien Gosselet

  111. Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells

    Article • Brain Research, June 2013, Elsevier

    Pr. Fabien Gosselet

  112. Truncated thioredoxin (Trx‐80) promotes pro‐inflammatory macrophages of the M1 phenotype and enhances atherosclerosis

    Article • Journal of Cellular Physiology, March 2013, Wiley

    Pr. Fabien Gosselet

  113. The LXR/RXR Approaches in Alzheimer’s Disease: Is the Blood-Bra in Barrier the Forgotten Partner?

    Article • Journal of Alzheimer’s Disease & Parkinsonism, January 2013, OMICS Publishing Group

    Pr. Fabien Gosselet

  114. Apolipoprotéine E et intégrité de la barrière hémato-encéphalique

    Article • médecine/sciences, November 2012, EDP Sciences

    Pr. Fabien Gosselet

  115. Brain Pericytes ABCA1 Expression Mediates Cholesterol Efflux but not Cellular Amyloid-β Peptide Accumulation

    Article • Journal of Alzheimer’s Disease, June 2012, IOS Press

    Pr. Fabien Gosselet

  116. Brain pericytes from stress-susceptible pigs increase blood-brain barrier permeability in vitro

    Article • Fluids and Barriers of the CNS, January 2012, Springer Science + Business Media

    Pr. Fabien Gosselet

  117. A differential proteomic approach identifies structural and functional components that contribute to the differentiation of brain capillary endothelial cells

    Article • Journal of Proteomics, December 2011, Elsevier

    Dr LUC CAMOIN, Pr. Fabien Gosselet

  118. Modelling the Neurovascular Unit and the Blood-Brain Barrier with the Unique Function of Pericytes

    Article • Current Neurovascular Research, November 2011, Bentham Science Publishers

    Pr. Fabien Gosselet

  119. La barrière hémato-encéphalique

    Article • médecine/sciences, November 2011, EDP Sciences

    Pr. Fabien Gosselet

  120. Erratum

    Article • Journal of Alzheimer’s Disease, March 2011, SAGE Publications

    Pr. Fabien Gosselet

  121. The Mysterious Link between Cholesterol and Alzheimer?s Disease: Is the Blood-Brain Barrier a Suspect?

    Article • Journal of Alzheimer’s Disease & Parkinsonism, January 2011, OMICS Publishing Group

    Pr. Fabien Gosselet

  122. Apical-to-Basolateral Transport of Amyloid-β Peptides through Blood-Brain Barrier Cells is Mediated by the Receptor for Advanced Glycation End-Products and is Restricted by P-Glycoprotein

    Article • Journal of Alzheimer’s Disease, November 2010, IOS Press

    Pr. Fabien Gosselet

  123. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood–brain barrier: Use of an in vitro model

    Article • Brain Research, January 2009, Elsevier

    Pr. Fabien Gosselet

  124. Physiological Pathway for Low-Density Lipoproteins across the Blood-Brain Barrier: Transcytosis through Brain Capillary Endothelial Cells In Vitro

    Article • Endothelium, January 2008, Taylor & Francis

    Pr. Fabien Gosselet

  125. BMP2 and BMP6 control p57Kip2 expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes

    Article • Cellular Signalling, April 2007, Elsevier

    Pr. Fabien Gosselet

  126. UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis

    Article • Photochemical & Photobiological Sciences, August 2003, Springer Science + Business Media

    Pr. Fabien Gosselet